Chronic renal insufficiency (CRI) has been associated with an increased risk of cardiovascular disease in some studies, but the relation of CRI to cardiovascular mortality in the United States is not known. The contribution of CRI to cardiovascular disease mortality may be greatest in the elderly and in blacks, because CRI is more prevalent in these groups. Furthermore, the pathologic mechanisms for the increase in all-cause mortality associated with CRI are largely unknown. This project will help to define the effect of CRI on cardiovascular public health in the United States, and will evaluate the potential underlying mechanisms. Using data from the Second National Health and Nutritional Examination Survey Mortality Study, this project will estimate the independent association of CRI with cardiovascular mortality in the United States, and the contribution of CRI (the population attributable risk) to cardiovascular mortality within subgroups based on age, race and sex. Further analyses will compare the different methods for defining CRI, based on serum creatinine, estimated creatinine clearance, and estimated glomerular filtration rate. The association of each measurement of renal function with cardiovascular mortality will be characterized by subgroups of age, race and sex. This project will also examine the association of CRI with potential traditional and novel cardiovascular risk factors, using data from the Third National Health and Nutritional Examination Study. The hypothesis that CRI is associated with unique abnormalities, including inflammation, metabolic alterations, and dyslipidemia, will be evaluated by comparing serum measurements in participants with and without CRI.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Research Grants (R03)
Project #
1R03HL068099-01
Application #
6369005
Study Section
Clinical Trials Review Committee (CLTR)
Program Officer
Wolz, Michael
Project Start
2001-07-01
Project End
2003-12-31
Budget Start
2001-07-01
Budget End
2003-12-31
Support Year
1
Fiscal Year
2001
Total Cost
$74,500
Indirect Cost
Name
Northern California Institute Research & Education
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94121
Shlipak, Michael G; Ix, Joachim H; Bibbins-Domingo, Kirsten et al. (2008) Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med 121:50-7
Hsu, Chi-yuan; Vittinghoff, Eric; Lin, Feng et al. (2004) The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141:95-101
Wiese, Jeff; McPherson, Steve; Odden, Michelle C et al. (2004) Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch Intern Med 164:1334-40
Shlipak, Michael G; Chertow, Glenn C; Massie, Barry M (2003) Beware the rising creatinine level. J Card Fail 9:26-8
Shlipak, Michael G; Fried, Linda F; Crump, Casey et al. (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92
Shlipak, Michael G (2003) Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 138:917-24
Hsu, Chi-Yuan; Lin, Feng; Vittinghoff, Eric et al. (2003) Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14:2902-7
Shlipak, Michael G; Fried, Linda F; Crump, Casey et al. (2002) Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 62:997-1004
Shlipak, Michael G; Heidenreich, Paul A; Noguchi, Haruko et al. (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555-62